1. Introduction
Benign prostate hyperplasia (BPH) has been a very common pathology in the male population over the past 50 years (50% incidence) associated with lower urinary tract symptoms (LUTSs) that affect the quality of life [
1]. Treatment options for BPH include medication, surgery (transurethral incision of prostate, TUIP, and transurethral resection of the prostate, TURP), and minimally invasive treatments, like prostatic artery embolization (PAE) and prostatic urethral lift. Prostatic artery embolization is a minimally invasive treatment for BPH that consists of the supra-selective embolization of prostatic arteries (PAs), which reduces the volume of the prostate parenchyma and improves the symptomatology of the patients. Described in 2010 as a therapy for BPH by Carnevale, the procedure has been adapted and developed by several interventional radiology centers [
2].
Post-procedural outcomes for PAE and TURP are similar regarding LUTSs; however, PAE has advantages such as preservation of the urinary and sexual functions. Studies on the TURP procedure note adverse reactions such as bleeding, infection, and urethral stricture, as well as increased morbidity with retrograde ejaculation and urinary incontinence [
3]. Other important advantages of PAE are the minimally invasive nature of the procedure with no need for hospitalization or general anesthesia and the increased quality of life; nevertheless, incidents such as non-targeted embolization (NTE) of the bladder or rectum causing pelvic pain or rectal bleeding can occur; usually, the area of ischemia is small and the adverse reactions are transient and do not need treatment [
4,
5]. Penile ischemia is possible in the case of NTE due to the vascularization origin from the IIA branches, but at the same time, erectile dysfunction after PAE has not been reported [
6]. The high success rate of prostatic artery embolization procedures and the decrease rate of post-procedural incidents is directly related to good knowledge of the prostatic vascularization and its variability [
4].
The indication for PAE is considered to be patients with moderate to severe lower urinary tract symptoms in direct relation to a benign prostatic obstruction who do not respond to medication or have a severe adverse reaction to it [
7,
8].
The main purpose of this paper is to present the procedural protocol in our department and the results of the study on the arterial origin of the PA. We expect this study to serve as a guide for young interventional radiologists who want to perform PAE by presenting the protocol of the procedure from our department and the main challenges we have encountered [
9].
2. Materials and Methods
This retrospective study is based on digital subtraction angiography (DSA) examinations of 35 male patients, aged 50–83 with BPH that undergo PAE. The procedures were performed from March 2021 to May 2023 by two interventional radiologists in the Endovascular Network department. All patients have agreed to participate in this study by signing the preprocedural consent and information form.
In our department for PAE, we used the left brachial approach with a 5F introducer (Terumo™, West Collins Avenue Lakewood, CO, USA) with a 5F JR (125 cm) shape catheter (Merit Medical™, South Jordan, UT, USA), a Radiofocus™ guide wire 0.035″ (180 cm) from Terumo™, and a nonionic contrast agent (Omnipaque™ 350 mL l/mL GE Healthcare™, Chicago, IL, USA). For the supra-selective catheterization of prostatic arteries, we used a Direxion Transend 14™ and pre-loaded torqueable microcatheter from Boston Scientific™ (Marlborough, MA, USA).
We used five steps in the arterial mapping in order to identify the PA and successfully obtain the supra-selective catheterization:
Contralateral 45° with 10° cranio-caudal-oriented DSA in order to catheterize the internal iliac artery.
Ipsilateral 45° with 10° cranio-caudal-oriented DSA in order to obtain the mapping of the main branches of the iliac artery and include them in one of the Yamaki classifications (
Table 1) [
10];
After we identified the four main branches (superior gluteal artery, inferior gluteal artery, obturator artery, internal pudendal artery), we searched for the PA artery, which usually has a characteristic corkscrew aspect and parallel trajectory with the IPA.
The next step is represented by the positioning of the JR catheter in an optimal position near the origin of the PA and catheterization with the Direxion™ microcatheter.
Study the aspect of the PA: we can find two branches of the PA, which are represented by the posterior PA (vascularization of the prostatic capsule) and anterior PA (vascularization of the prostatic parenchyma) [
2].
This five-step method of mapping the arterial vascularization of the pelvis has the purpose of offering an organized search of the PA and reducing the exposure to radiation while concluding in a proper prostatic embolization.
Variabilities that must be taken into consideration when identifying the PA:
Type of internal iliac artery (IIA) branching pattern from Yamaki classification which helps to identify possible origins of the PA [
3].
Prostatic arteries realize the vascularization of the prostate, the anterior for the prostatic parenchyma and the posterior prostatic arteries for the prostatic capsule. Depending on the variability, we can frequently find a common trunk and a distal bifurcation near the prostate, but there are also cases of two PAs with different origins (
Figure 1) [
11].
There are cases when we can identify IPA and IPA accessories, which must not be confused with the PA. At the level of accessory IPAs, we can find the origin of the middle rectal artery, which has a characteristic pattern of enhancement that cannot be mistaken with the prostatic blush [
12] (
Figure 2);
3. Results
We were able to identify the origin of the PA of all patients included in this study with the most common origin found at the level of IPA (37.1% of 70 hemi-pelvises) followed by the anterior gluteal trunk above the bifurcation (27.1% of 70 hemi-pelvises), the superior vesical artery (21.4% of 70 hemi-pelvises), and the obturator artery (11.4% of 70 hemi-pelvises). Less frequent origins were found at the level of the inferior gluteal artery (2.8% of 70 hemi-pelvises). Compared with other studies, the percentage of each origin is slightly different but the main order of frequency is maintained [
13,
14,
15] (
Table 2).
3.1. Prostatic Artery Origin
3.1.1. PA with Origin from IPA
We can consider this example as the ideal patient for PA catheterization from the point of view of the vascular anatomy. Nevertheless, it is mandatory to respect all the steps of the procedure and verify the catheterized artery before embolization(
Figure 3).
3.1.2. PA with Origin from Anterior Gluteal Trunk
The origin at this level is usually accessible for catheterization with the JR catheter due to its particular shape, as it can be placed near the origin of the PA, and it will offer good support and good handling for the Direxion microcatheter (
Figure 4).
3.1.3. PA with Origin from SVA
For this anatomic variant, it is important to place the microcatheter distally to the PA origin in order to avoid non-targeted embolization of the bladder (
Figure 5).
3.1.4. PA with Distal Origin from Internal Pudendal Artery
The most frequent origin of PA is from IPA, nevertheless distal origin is very rare and may be challenging to catheterize due to its long path and direction of the vessel (
Figure 6).
3.2. Importance of Supra-Selective Catheterization in Case of PA with Common Trunk or Anastomosis
3.2.1. PA origin with Common Trunk
We can often identify PAs that have a common trunk with the superior or inferior ves-ical artery (
Figure 7) that require the microcatheter to be placed after the origin of the vesical arteries in order to manage a targeted embolization.
3.2.2. Anastomoses of PA with Penile Artery
For arterial anastomosis and collaterals, we have to follow the same rule in order to obtain targeted embolization (
Figure 8); otherwise, embolization particles will reach unwanted territories and may cause small areas of necrosis. What are most common and with severe symptoms are the bladder, penis, and rectum, causing urinary and sexual function deficiency and ischemic rectitis with inferior abdominal pain, respectively [
2].
3.2.3. Middle Rectal Artery with Origin from PA
We can find cases of middle rectal artery with the origin at the level of posterior PA, and as a key finding we can search for the characteristic vertical blush of the rectal arteries. In this case we have to correct the position of the microcatheter at the level of the anterior PA in order to perform the targeted embolization and not damage the rectal tissue [
16]. Always before embolization, we have to demonstrate the correct position with DSA acquisition in which we can identify the prostatic blush (
Figure 9).
3.3. Post-Procedural Short-Term Complications
We report no major periprocedural events for any of the patients included in this study such as non-targeted embolization with areas of necrosis at the level of the rectum, bladder, or penis. None of the patients included in this study had vascular complications after the procedure such as pseudoaneurysms or arterial dissection. Minor post-procedural side-effects have been reported such as pelvic pain in the first 24 h at 22 of the patients from the 35 included in this study (62.8%).
4. Discussion
Because the PAE procedure has become increasingly popular in recent years, it is important to discuss in this paper the method and challenges encountered related to the anatomical variability of PA origin. The variability in the male pelvic arterial vascularization is significant; nevertheless, some patterns are identified as recurrent. Compared to the present literature, the results of this study agree with the scientific consensus that there are three most frequent origins, which are the IPA, anterior common trunk, and SVA. However, our paper, as well as the ones which we have cited, found different proportions of the main origins, which might be explained by regional differences. This is fundamental to improvement of the procedure, especially taking the exposure to radiation of both the patient and doctor into consideration.
PAE is a demanding procedure and the outcome is directly related to the skills and the knowledge of the performing doctor, so it is necessary to highlight certain helpful information. The left brachial with a 5F introducer represents a better approach that will make the catheterization of both sides of the pelvis easier and also result in less frequent post-procedural local complications.
The five aforementioned steps of arterial mapping before the embolization represent a coordinated search of the PA that will significantly reduce the time of the procedure and the radiation exposure to both the patient and the doctor, by having the typical anatomical variations in mind. When using the arterial mapping, we can correlate the results of the current study that will help identify the PA based on the most frequent or less frequent origins. The similar results of the current study compared to the cited studies represent a confirmation of the accuracy of our data.
The characteristic “cork-screw” aspect of the PA is helpful in identifying it in the numerous pelvic small vessels.
After the supra-selective catheterization of the PA, it is recommended to use 200–300 µm embolic particles highly diluted with contrast agent and saline solution injected slowly for the embolization. Repeated verification with DSA is needed in order to prevent embolization particle reflux from the PA in other arterial branches.
During the procedure, there are some challenges that can be encountered such as the angulation of the artery from the origin. The path and branches that may have an origin at this level are highly susceptible to variability and may represent a challenge for young interventional radiologists. The solution is represented by performing the end part of the microguide with a similar angle of the artery for a better navigation and catheterization.
BPH is one of the most frequent pathologies in the elderly male population; at the same time, atherosclerotic disease is very common in this age group. In many cases of PAE, it is expected to encounter vascular stenosis and tortuosity that will transform the catheterization of the prostatic artery in the most difficult part of the procedure and increase the radiation exposure to the patient and doctor [
17,
18,
19]. The position of the JR catheter is important and helpful in these cases because it can ensure the proper support for the microcatheter navigation through the atherosclerotic plaques.
It is required to identify the collaterals or anastomosis of the PA before embolization in order to take proper action to ensure targeted embolization. The most frequent collateral arteries are with middle rectal artery, inferior vesical arteries, and IPA. If supra-selective catheterization is not possible, micro-coil embolization of the branch is recommended in order to ensure a proper embolization [
6].
The endovascular navigation technique for the pelvic arterial supply discussed in this paper can find its application also in other special procedures that are intended to solve rare post-surgical complications such as bleeding and pseudoaneurysm that may occur. Cases with a very good outcome have been reported with a low morbidity [
20,
21]. It is essential to adapt the embolic material (coil, glue, particles) depending on the affected branch of the IIA.
Targeted embolization is one of the most important steps for a successful embolization procedure because it reduces the chances of post-procedural complications [
22]. All aspects discussed must be taken into consideration when embolization is performed in order to have an efficient procedure without other post-procedural complications.
5. Conclusions
The PAE procedure is a safe and effective method of treatment for LUTSs in BPH as long as there is proper knowledge of the technique and anatomic variability of the arterial vascularization in the pelvic region. Due to its minimally invasive nature and low rate of complications, the popularity of this procedure has increased in the past years.
Compared to other studies, we noticed a difference in the percentage of the origins, but the most frequent variations are agreed upon in literature. It is important for young interventional radiologists to be aware of all the possible origins of PAs in order to be able to catheterize the PA and offer a proper treatment to their patients with BPH.
Author Contributions
Conceptualization, A.Ș. and R.N.; methodology, G.I.; formal analysis, A.M.B. and I.A.S.; resources, R.N.; writing—original draft preparation, A.Ș. and R.T.I.; writing—review and editing. A.Ș. and A.N.M.; supervision F.M.F. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethic Committee of Endovascular Network in March 2021 with registration number 43/2021.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
Data are available upon request from the corresponding authors.
Acknowledgments
Publication of this paper was supported by the University of Medicine and Pharmacy Carol Davila, through the institutional program Publish not Perish.
Conflicts of Interest
The authors declare no conflict of interest.
Abbreviations
BPH | benign prostatic hyperplasia |
PAE | prostatic arterial embolization |
DSA | digital subtraction angiography |
PA | prostatic artery |
SGA | superior gluteal artery |
IGA | inferior gluteal artery |
OBT | obturator artery |
IIA | internal iliac artery |
SVA | superior vesical artery |
References
- Berry, S.J.; Coffey, D.S.; Walsh, P.C.; Ewing, L.L. The Development of Human Benign Prostatic Hyperplasia with Age. J. Urol. 1984, 132, 474–479. [Google Scholar] [CrossRef] [PubMed]
- Carnevale, F.C.; Antunes, A.A.; da Motta Leal Filho, J.M.; de Oliveira Cerri, L.M.; Baroni, R.H.; Marcelino, A.S.Z.; Freire, G.C.; Moreira, A.M.; Srougi, M.; Cerri, G.G. Prostatic Artery Embolization as a Primary Treatment for Benign Prostatic Hyperplasia: Preliminary Results in Two Patients. Cardiovasc. Interv. Radiol. 2010, 33, 355–361. [Google Scholar] [CrossRef]
- Ahyai, S.A.; Gilling, P.; Kaplan, S.A.; Kuntz, R.M.; Madersbacher, S.; Montorsi, F.; Speakman, M.J.; Stief, C.G. Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Enlargement. Eur. Urol. 2010, 58, 384–397. [Google Scholar] [CrossRef] [PubMed]
- Moreira, A.M.; de Assis, A.M.; Carnevale, F.C.; Antunes, A.A.; Srougi, M.; Cerri, G.G. A Review of Adverse Events Related to Prostatic Artery Embolization for Treatment of Bladder Outlet Obstruction Due to BPH. Cardiovasc. Interv. Radiol. 2017, 40, 1490–1500. [Google Scholar] [CrossRef] [PubMed]
- Jones, P.; Rai, B.P.; Nair, R.; Somani, B.K. Current Status of Prostate Artery Embolization for Lower Urinary Tract Symptoms: Review of World Literature. Urology 2015, 86, 676–681. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.D.; Huh, J.S.; Kim, Y.-J. Necrosis of the Penis with Multiple Vessel Atherosclerosis. World J. Mens Health 2014, 32, 66. [Google Scholar] [CrossRef] [PubMed]
- Picel, A.C.; Hsieh, T.-C.; Shapiro, R.M.; Vezeridis, A.M.; Isaacson, A.J. Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Patient Evaluation, Anatomy, and Technique for Successful Treatment. RadioGraphics 2019, 39, 1526–1548. [Google Scholar] [CrossRef] [PubMed]
- Pereira, J.; Bilhim, T.; Duarte, M.; Rio Tinto, H.; Fernandes, L.; Martins Pisco, J. Patient Selection and Counseling before Prostatic Arterial Embolization. Tech. Vasc. Interv. Radiol. 2012, 15, 270–275. [Google Scholar] [CrossRef]
- Moulin, B.; di Primio, M.; Vignaux, O.; Sarrazin, J.L.; Angelopoulos, G.; Hakime, A. Prostate Artery Embolization: Challenges, Tips, Tricks, and Perspectives. J. Pers. Med. 2022, 13, 87. [Google Scholar] [CrossRef]
- Yamaki, K.-I.; Saga, T.; Doi, Y.; Aida, K.; Yoshizuka, M. A Statistical Study of the Branching of the Human Internal Iliac Artery. Kurume Med. J. 1998, 45, 333–340. [Google Scholar] [CrossRef]
- de Assis, A.M.; Moreira, A.M.; de Paula Rodrigues, V.C.; Harward, S.H.; Antunes, A.A.; Srougi, M.; Carnevale, F.C. Pelvic Arterial Anatomy Relevant to Prostatic Artery Embolisation and Proposal for Angiographic Classification. Cardiovasc. Interv. Radiol. 2015, 38, 855–861. [Google Scholar] [CrossRef]
- Nguyen Xuan, H.; do Huy, H.; Nguyen Thi Bich, N.; Phan Hoang, G.; le Van, K.; Nguyen Duy, T.; Anh Tran, T.; Thi Nga, V.; Bui Minh, L. Anatomical Characteristics and Variants of Prostatic Artery in Patients of Benign Hyperplasia Prostate by Digital Subtraction Angiography. Open Access Maced. J. Med. Sci. 2019, 7, 4204–4208. [Google Scholar] [CrossRef] [PubMed]
- Bilhim, T.; Pisco, J.M.; Rio Tinto, H.; Fernandes, L.; Pinheiro, L.C.; Furtado, A.; Casal, D.; Duarte, M.; Pereira, J.; Oliveira, A.G.; et al. Prostatic arterial supply: Anatomic and imaging findings relevant for selective arterial embolization. J. Vasc. Interv. Radiol. 2012, 23, 1403–1415. [Google Scholar] [CrossRef] [PubMed]
- Bilhim, T.; Pisco, J.M.; Furtado, A.; Casal, D.; Pais, D.; Pinheiro, L.C.; O’Neill, J.E.G. Prostatic arterial supply: Demonstration by multirow detector Angio CT and Catheter Angiography. Eur. Radiol. 2011, 21, 1119–1126. [Google Scholar] [CrossRef] [PubMed]
- Garcia-Monaco, R.; Garategui, L.; Kizilevsky, N.; Peralta, O.; Rodriguez, P.; Palacios-Jaraquemada, J. Human cadaveric specimen study of the prostatic arterial anatomy: Implications for arterial embolization. J. Vasc. Interv. Radiol. 2014, 25, 315–322. [Google Scholar] [CrossRef] [PubMed]
- Moreira, A.M.; Marques CF, S.; Antunes, A.A.; Nahas, C.S.R.; Nahas, S.C.; de Gregorio Ariza, M.Á.; Carnevale, F.C. Transient Ischemic Rectitis as a Potential Complication after Prostatic Artery Embolization: Case Report and Review of the Literature. Cardiovasc. Interv. Radiol. 2013, 36, 1690–1694. [Google Scholar] [CrossRef]
- Bin Lim, K. Epidemiology of clinical benign prostatic hyperplasia. Asian J. Urol. 2017, 4, 148–151. [Google Scholar] [CrossRef]
- Taylor, B.C.; Wilt, T.J.; Fink, H.A.; Lambert, L.C.; Marshall, L.M.; Hoffman, A.R.; Beer, T.M.; Bauer, D.C.; Zmuda, J.M.; Orwoll, E.S. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: The MrOS study. Urology 2006, 68, 804–809. [Google Scholar] [CrossRef]
- Jaffer, F.A.; O’Donnell, C.J.; Larson, M.G.; Chan, S.K.; Kissinger, K.B.; Kupka, M.J.; Salton, C.; Botnar, R.M.; Levy, D.; Manning, W.J. Age and Sex Distribution of Subclinical Aortic Atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 849–854. [Google Scholar] [CrossRef]
- Gonzalez-Araiza, G.; Haddad, L.; Patel, S.; Karageorgiou, J. Percutaneous Embolization of a Postsurgical Prostatic Artery Pseudoaneurysm and Arteriovenous Fistula. J. Vasc. Interv. Radiol. 2019, 30, 269–271. [Google Scholar] [CrossRef]
- della Corte, M.; Amparore, D.; Sica, M.; Clemente, E.; Mazzuca, D.; Manfredi, M.; Fiori, C.; Porpiglia, F. Pseudoaneurysm after Radical Prostatectomy: A Case Report and Narrative Literature Review. Surgeries 2022, 3, 229–241. [Google Scholar] [CrossRef]
- Carnevale, F.C.; Moreira, A.M.; Harward, S.H.; Bhatia, S.; de Assis, A.M.; Srougi, M.; Cerri, G.G.; Antunes, A.A. Recurrence of Lower Urinary Tract Symptoms Following Prostate Artery Embolization for Benign Hyperplasia: Single Center Experience Comparing Two Techniques. Cardiovasc. Interv. Radiol. 2017, 40, 366–374. [Google Scholar] [CrossRef] [PubMed]
| Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).